Knight Therapeutics, Inc. (GUD.TO)
8.19
+0.24
(+3.02%)
CAD |
TSX |
May 29, 16:00
Knight Therapeutics Market Cap : 804.09M for May 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| HLS Therapeutics, Inc. | 143.55M |
| Bausch Health Cos., Inc. | 2.767B |
| Cipher Pharmaceuticals, Inc. | 423.78M |
| BioSyent, Inc. | 159.68M |
| Revive Therapeutics Ltd. | 15.25M |
Market Cap Related Metrics
| PE Ratio | 141.94 |
| PS Ratio | 1.594 |
| Price to Book Value | 1.021 |
| Price to Free Cash Flow | 12.13 |
| Price | 8.19 |
| Earnings Yield | 0.70% |
| Operating PE Ratio | 59.11 |
| Normalized PE Ratio | 100.37 |